Drug Search Results
More Filters [+]

Tenatoprazole

Alternative Names: tenatoprazole
Latest Update: 2024-02-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Proton Pump Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Steba Biotech
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tenatoprazole

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Esophagitis, Peptic

Phase 1: Duodenal Ulcer|Esophagitis|Stomach Ulcer|Gastroesophageal Reflux

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

HPD/STU(-Na) 05819N/TU 1.41

P1

Completed

Stomach Ulcer|Gastroesophageal Reflux|Duodenal Ulcer|Esophagitis

2006-11-01

HEC/STU(-Na)05816N/TU 2.05

P2

Suspended

Esophagitis, Peptic

None

Recent News Events